The article referenced is a CASE REPORT listed in Frontiers in Immunology. The only substantive content available from the supplied source was the article title and journal metadata. No full-text case narrative, figures, tables, or patient-level data were present in the source material provided for this rewrite.
The article title reports an unusual initial clinical manifestation: small bowel obstruction as the presenting feature of Strongyloides hyperinfection syndrome. This presentation and the association are explicit in the title; the source text supplied here did not include any additional clinical details such as symptoms, duration, physical examination findings, or imaging results.
The title indicates that metagenomic next-generation sequencing (mNGS) testing was negative. The source content available for this task did not include the full diagnostic workup, laboratory values, stool or sputum microscopy, serology, culture, PCR, histopathology, or other microbiologic evidence of Strongyloides infection. Details about the timing of mNGS testing, specimen type, laboratory methods, or interpretation were not reported in the provided source.
The title specifies antecedent glucocorticoid exposure and an underlying diagnosis of COPD. No further information was provided about the dose, duration, route of glucocorticoids, whether systemic or inhaled, or other immunosuppressive therapies. The source material did not report comorbidities, travel or epidemiologic history, prior eosinophilia, or other risk-modifying features.
The title states the case was fatal. The available source did not include details on the proximate cause of death, whether death followed progressive infection, complications of bowel obstruction, multi-organ failure, or other events. No timeline of clinical deterioration, interventions attempted, or end-of-life considerations was supplied.
The supplied source text consisted of journal navigation content and did not include the body of the case report. Specifically, the following expected elements were not reported in the provided material and therefore cannot be summarized here:
Because these items were not present in the source material available for this task, no assumptions or invented data have been included in this rewrite.
From the title alone, the case raises clinically important signals: an atypical primary presentation (intestinal obstruction) associated with a severe parasitic syndrome and an instance of negative mNGS despite the clinical diagnosis, in the setting of antecedent glucocorticoid exposure and COPD, culminating in a fatal outcome. However, the absence of the full case text in the provided source prevents extraction of actionable clinical details.
For clinicians and for readers of case reports, full case transparency is essential. When the full report is available, readers should expect clear documentation of:
None of these details were included in the source text provided here; they would need to be reviewed in the full published article to permit clinical interpretation or to inform practice changes.
The title published in Frontiers in Immunology indicates a fatal case of Strongyloides hyperinfection syndrome presenting initially as small bowel obstruction, reported as mNGS-negative, in a patient with glucocorticoid exposure and COPD. The supplied source contained only website and journal navigation material and did not include the body of the case report. Therefore, this rewrite reports only the facts explicitly given in the title and identifies the specific clinical details that were not reported in the source material provided for this task. Clinicians should consult the full published article for complete patient data, diagnostic evidence, management details, and the authors’ discussion and conclusions.